U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07061847) titled 'Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines' on July 01.
Brief Summary: The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DRUG: Lidocaine (drug)
The study intervention involves the use of 1% cardiac preservative-free lidocaine...